CLEC10A marks an MHC class II-high tumour myeloid state that lies in T-cell-rich neighbourhoods, and its survival association is seen in MYCN non-amplified neuroblastoma
Background. CLEC10A (CD301) is widely used as a marker of CD1c-positive conventional type 2 dendritic cells (cDC2). Whether it carries prognostic informati